Technology • Enterprise Application Software & Agentic CRM • SIC 7372
$229.17 ▼ -1.73
(-0.75%)
MKT CAP: $191.96B • VOL: 7.89M
52W L $146 52W H $269
CRM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-02 | FY 2024
FILED 2026-03-02 | FY 2023
FILED 2026-03-02 | FY 2022
FILED 2025-03-05 | FY 2021
FILED 2024-03-06 |
|---|---|---|---|---|---|
| Revenue (Total Sales) | $41.52B | $37.90B | $34.86B | $31.35B | $26.49B |
| YoY Revenue Growth % | +9.6% | +8.7% | +11.2% | +18.4% | +24.7% |
| Gross Profit | $32.26B | $29.25B | $26.32B | $22.99B | $19.47B |
| Gross Margin % | 77.7% | 77.2% | 75.5% | 73.3% | 73.5% |
| Research & Development (R&D) | $5.99B | $5.49B | $4.91B | $5.05B | $4.46B |
| Operating Income (EBIT) | $8.33B | $7.21B | $5.01B | $1.03B | $548.0M |
| Operating Margin % | 20.1% | 19.0% | 14.4% | 3.3% | 2.1% |
| Net Income (GAAP) | $7.46B | $6.20B | $4.14B | $208.0M | $1.44B |
| EBITDA (Normalized) | $9.53B | $8.21B | $6.11B | $1.93B | $1.23B |
| Diluted EPS ($/sh) | $7.80 | $6.36 | $4.20 | $0.21 | $1.48 |
| Operating Cash Flow (OCF) | $15.00B | $13.09B | $10.23B | $7.11B | $6.00B |
| Capital Expenditures (CapEx) | $594.0M | $658.0M | $736.0M | $798.0M | $717.0M |
| Free Cash Flow (FCF) | $14.40B | $12.43B | $9.50B | $6.31B | $5.28B |
| FCF Margin % | 34.7% | 32.8% | 27.3% | 20.1% | 19.9% |
| Return on Invested Capital (ROIC %) | 9.9% | 9.4% | 6.5% | 1.3% | 0.7% |
| Cash & Short-Term Equivalents | $7.33B | $8.85B | $8.47B | $7.02B | $5.46B |
| Total Debt (Short + Long Term) | $14.44B | $8.43B | $9.43B | $10.60B | $10.60B |
| Total Stockholders' Equity | $59.14B | $61.17B | $59.65B | $58.36B | $58.13B |
| LINE ITEM (USD / %) | Q2 2026
FILED 2026-08-27 | Q1 2026
FILED 2026-05-28 | Q4 2025
FILED 2026-03-02 | Q3 2025
FILED 2025-12-04 | Q2 2025
FILED 2026-08-27 | Q1 2025
FILED 2026-05-28 |
|---|---|---|---|---|---|---|
| Revenue (Total Sales) | $11.35B | $11.13B | $11.20B | $10.26B | $10.24B | $9.83B |
| YoY Revenue Growth % | +10.8% | +13.3% | +12.1% | +8.6% | +9.8% | +7.6% |
| Gross Profit | $8.70B | $8.56B | $8.69B | $8.00B | $7.99B | $7.56B |
| Gross Margin % | 76.7% | 76.9% | 77.6% | 78.0% | 78.1% | 77.0% |
| Research & Development (R&D) | $1.69B | $1.63B | $1.62B | $1.43B | $1.48B | $1.46B |
| Operating Income (EBIT) | $2.33B | $2.35B | $1.87B | $2.19B | $2.33B | $1.94B |
| Operating Margin % | 20.6% | 21.1% | 16.7% | 21.3% | 22.8% | 19.8% |
| Net Income (GAAP) | $3.53B | $2.11B | $1.94B | $2.09B | $1.89B | $1.54B |
| EBITDA (Normalized) | $3.30B | $3.33B | $2.06B | $3.04B | $3.15B | $2.79B |
| Diluted EPS ($/sh) | $4.29 | $2.42 | $2.06 | $2.19 | $1.96 | $1.59 |
| Operating Cash Flow (OCF) | $1.27B | $6.70B | $5.46B | $2.32B | $740.0M | $6.48B |
| Capital Expenditures (CapEx) | $171.0M | $145.0M | $141.0M | $139.0M | $135.0M | $179.0M |
| Free Cash Flow (FCF) | $1.10B | $6.56B | $5.32B | $2.18B | $605.0M | $6.30B |
| FCF Margin % | 9.7% | 58.9% | 47.5% | 21.2% | 5.9% | 64.1% |
| Return on Invested Capital (ROIC %) | 10.6% | 11.5% | 8.9% | 11.6% | 12.4% | 10.6% |
| Cash & Short-Term Equivalents | $8.31B | $8.94B | $7.33B | $8.98B | $10.37B | $10.93B |
| Total Debt (Short + Long Term) | $39.29B | $39.28B | $14.44B | $8.44B | $8.44B | $8.44B |
| Total Stockholders' Equity | $38.38B | $34.23B | $59.14B | $60.02B | $61.33B | $60.67B |